Epazz DeskFlex room scheduling software launches a vaccine management solution to simplify COVID-19 vaccination tracking in the workplace

Chicago, Illinois–(Newsfile Corp. – March 31, 2021) – EPAZZ Inc. DeskFlex (OTC Pink: EPAZ), a leading provider of cloud-based, mission-critical software solutions, announced today the launching of the DeskFlex’s Vaccine Management solution for COVID vaccination initiatives among businesses and organizations.

At present, three (3) vaccines are FDA-approved and recommended to prevent contracting the virus. These include the Pfizer-BioNTech vaccine, Moderna vaccine, and Johnson & Johnson’s Janssen vaccine. With mass vaccination activities aiming to vaccinate at least 70% of the total population, several businesses and companies are doing their part in speeding up and tracking vaccination efforts among their staff and team members.

The DeskFlex Vaccine Management solution is one of its COVID compliant features that allow employees to notify the company about their vaccination status against the COVID-19 virus. It monitors and tracks the employees’ vaccination history and their subsequent scheduled doses. It allows their team members to upload vaccination certificates to the system. It is an essential software feature to support contact tracing and uphold safety protocols in the workplace.

According to Shaun Passley, Ph.D., Chairman, and CEO of Epazz, Inc.,

Advertisement

“DeskFlex vaccine management solution will further secure the workplace and schools from COVID-19 infections. When administrators identify those who haven’t had the vaccine, they can make the appropriate decisions for the good of the majority.”

DeskFlex vaccine management software will remind the staff of their following vaccination schedule or upcoming booster shots by sending out email and text notifications. The system keeps accurate and updated details on the Vaccination Date, Vaccination Type, Required Booster Shot, Schedule of Booster Shot, Completed Booster Shot, and Date of Booster Shot Completion.

Using DeskFlex’s vaccine management solution, the company admins can manage their workforce well. With the employees’ submitted vaccination certificates, they can purposefully decide whether to revisit their health and safety protocols in the workplace and change their operations management.

DeskFlex’s vaccine management software aims to reinforce every workplace’s health and safety measures. DeskFlex desk booking software solution takes pride in providing industries with innovative COVID-compliant software features. Among the COVID-compliant features include Dynamic Scheduling, Capacity Limits, Manage Survey, Visitor Management, Bluetooth Beacons, Automatic Desk Sanitation, Contactless Room Displays, and many more.

About DeskFlex.com

Advertisement

DeskFlex is a desk booking solution and room reservation software useful in booking conference rooms, meeting rooms, workspaces, desks, car parking spaces, and office equipment. DeskFlex meeting room scheduling system helps office managers accommodate remote workers’ time in the office, reducing rent and facility costs. DeskFlex lets employees reserve desks in advance or claim desks right away. It adjusts the telephone switch (PBX), so calls ring at the “desk du jour.” DeskFlex includes check-in, point-and-click floor maps, a web browser, a local kiosk, Outlook integration, and conference room scheduling.

About Epazz, Inc. (www.epazz.com)

Epazz, Inc., is a leading cloud-based software company that specializes in providing customized cloud applications to the corporate world, higher-education institutions, and the public sector. Epazz BoxesOS™ v3.0 is a complete web-based software package for small- to mid-size businesses, Fortune 500 enterprises, government agencies, and higher education institutions. BoxesOS provides many of the web-based applications organizations would otherwise need to purchase separately. Epazz’s other products are K9Sky.com kennel software and the Provitrac applicant tracking system.

SAFE HARBOR

This is the “Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: certain statements contained in this press release are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can generally be identified by the use of forward-looking words such as “may,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” and “continue” (or the negation thereof) or similar terminology. Such forward-looking statements are subject to risks, uncertainties, and other factors that could cause actual results to differ materially from future results or those implied by such forward-looking statements. Investors are cautioned that no forward-looking statement is a guarantee of future performance and that actual results may differ materially from those contemplated by such forward-looking statements. Epazz, Inc. assumes no obligation and has no intention of updating these forward-looking statements. It has no obligation to update or correct information prepared by third parties that are not paid for by Epazz, Inc. Investors are encouraged to review Epazz, Inc.’s public filings on SEC.gov and otcmarkets.com, including its unaudited and audited financial statements and its OTC market filings, which contain general business information about the company’s operations, results of operations, and risks associated with the company and its operations.

Advertisement

CONTACT: For more information, please contact

Investor Relations
[email protected]
(312) 955-8161
www.epazz.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/78991